Trending News

Cancer cell
#Cancer research #Cancer therapeutics #Oncology #World Cancer Day

World Cancer Day: Five key cancer drug discoveries of the year so far

For World Cancer Day, Diana Spencer collates five most significant oncology research advances so far in 2025. An AI drug discovery breakthrough Results of an in vivo mouse colorectal cancer model study have shown a 60% life extension for Oxford Drug Design’s first-in-class approach against multiple… Read More

#Cancer Research #News #Trending News

Quantum computer
#Artificial intelligence (AI) #Insilico Medicine #Oncology #Quantum computing

Quantum computing approach targets ‘undruggable’ protein

A study co-led by University of Toronto (U of T) researchers and Insilico Medicine has demonstrated the potential of quantum computing and artificial intelligence (AI) to transform the drug discovery pipeline.  “It’s an exciting time to be working at the interface of chemistry, quantum computing and AI. Read More

#Cancer Research #News #Trending News

FDA
#AstraZeneca #FDA #Lymphoma #Oncology

First US approval for first-line BTK inhibitor for mantle cell lymphoma

The US Food and Drug Administration (FDA) has granted approval to acalabrutinib (Calquence) with bendamustine and rituximab for adults with previously untreated mantle cell lymphoma (MCL) who are ineligible for autologous hematopoietic stem cell transplantation (HSCT).  The regulator also granted approval to acalabrutinib as a single agent for adults with… Read More

#News #Regulatory #Trending News

Colorectal cancer
#Barts Institute #Bowel cancer #Colorectal cancer #Immunotherapy #Oncology #The Francis Crick Institute

CD74 level predicts immunotherapy response in bowel cancer

The amount of a protein called CD74 can indicate which people with bowel cancer may respond best to immunotherapy, new research has revealed.  If integrated into the clinic, the researchers at the Francis Crick Institute and Barts Cancer Institute, Queen Mary University of London, say testing for… Read More

#Cancer Research #News #Trending News

Eye
#Beam Therapeutics #Gene editing #Genetic engineering #Stargardt disease

Base editing technique could treat retinal diseases

Researchers have developed a gene editing therapy that could potentially treat Stargardt disease, the most common form of inherited macular degeneration.   The study, published in Nature Medicine, demonstrates the therapeutic use of a precision gene editing technology called base editing. … Read More

#News #Trending News

Pancreatic cells
#allogeneic cell therapies #Cell therapy #Diabetes #Sana Biotechnology #Type 1 diabetes

First evidence of cell transplant without immunosuppression

Positive results have been revealed from the first-in-human study transplanting an islet cell therapy into a patient with type 1 diabetes without the use of immunosuppression.  The study was investigating Sana Biotechnology’s UP421, an allogeneic primary islet cell therapy that has been engineered with… Read More

#News #Trending News

#Collaboration #Gene therapy #Lipid based nanoparticle (LNP) #Orna Therapeutics #Vertex

Vertex signs multimillion dollar deal with Orna Therapeutics

Vertex Pharmaceuticals and Orna Therapeutics have announced plans to partner on gene therapies for sickle cell disease (SCD) and transfusion-dependent beta thalassemia (TDT).  The three-year strategic research collaboration will utilise Orna’s lipid nanoparticle (LNP) delivery solutions.  In return Orna will receive upfront payments of $65 million, including an investment in… Read More

#Business & Investment #News #Trending News

#Artificial intelligence (AI) #Drug discovery #FDA #Regulatory

FDA issues first guidance on the use of AI in drug development

The US Food and Drug Administration (FDA) has issued the first guidance on the use of artificial intelligence (AI) for the development of drug and biological products.  The draft guidance provides recommendations on the use of AI to support a regulatory decision about a drug or biological product’s safety, effectiveness… Read More

#News #Regulatory #Trending News

Stem cell transplant
#Graft vs Host Disease #Haematology #JAK inhibitor #Stem cells #Washington University School of Medicine

JAK inhibitor prevents GvHD in ‘half-matched’ stem cell transplants

Adding a new drug to standard care for stem cell transplant recipients may reduce graft-versus-host disease (GvHD), according to an early-stage clinical trial conducted at Washington University School of Medicine in St Louis.   The trial showed that patients being treated for various blood cancers tolerated the… Read More

#News #Trending News

Test for KRAS mutation
#Antibody #Combination therapy #KRAS #Oncology #University of California San Francisco

Precision drug, antibody and radiation therapy kills tumours

Scientists have found a way to combine a precision drug therapy with an antibody and radiation to eliminate tumours without causing side effects.  “This is a one-two punch,” said Charly Craik, Professor of Pharmaceutical Chemistry at University of California, San Francisco (UCSF) and co-senior author of the… Read More

#News #Trending News

#Artificial intelligence (AI) #Financing #Large language model (LLM) #SandboxAQ

AI drug discovery company announces $300m funding

SandboxAQ today announced a round of more than $300 million, which valued the company at $5.3 billion on a pre-money basis. The money came from investors Fred Alger Management, T Rowe Price Associates, Mumtalakat, Parkway Venture Capital, Breyer Capital, Rizvi Traverse, S32, US Innovative Technology Fund, Ava Investments, Eric Schmidt,… Read More

#Business & Investment #News #Trending News

FDA
#Clinical trial #Drug discovery #FDA #Regulatory #SpliceBio #Stargardt disease

First-ever FDA IND for a protein splicing gene therapy

The US Food & Drug Administration (FDA) has cleared an investigational new drug (IND) application for SpliceBio’s lead programme SB-007, a clinical-stage therapeutic addressing the root genetic cause of Stargardt disease with the potential to treat all patients across all ABCA4 mutations. The SpliceBio study uses protein splicing to address… Read More

#News #Regulatory #Trending News

#Artificial intelligence (AI) #BenevolentAI #Business #Drug discovery

BenevolentAI announces layoffs as it plans to delist and refocus

BenevolentAI has unveiled a major strategic overhaul, which it says will return the company to its founding TechBio mission.   The company has initiated significant organisational and budgetary changes that extend into 2027 and is also exploring options to delist from Euronext Amsterdam.  Kenneth Mulvany, Executive Chairman, Founder and activist shareholder… Read More

#Business & Investment #News #Trending News

gut epithelium
#Antidepressants #Anxiety disorder #Depression #Gut-brain interaction #Pregnancy

Could the gut epithelium be a new target for antidepressants?

Researchers have discovered new connections between the gut and brain that hold promise for more targeted treatments for depression and anxiety.  The findings could also help prevent digestive issues in children by limiting the transmission of antidepressants during pregnancy.   The study,… Read More

#News #Trending News